Nepetin inhibits osteoclastogenesis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signalling pathway, and autophagy

Aseptic prosthetic loosening due to wear particle–induced inflammatory osteolysis is the main cause of failure for artificial joint replacement. The inflammatory response and the production of pro‐osteoclastic factors lead to elevation of osteoclast formation and excessive activity results in extens...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular and molecular medicine Vol. 24; no. 24; pp. 14366 - 14380
Main Authors Chu, Binxiang, Chen, Shenao, Zheng, Xiaohe, Ye, Jiajing, Cheng, Xu, Zhang, Liwei, Guo, Di, Wang, Peng, Hong, Dun, Hong, Zhenghua
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.12.2020
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aseptic prosthetic loosening due to wear particle–induced inflammatory osteolysis is the main cause of failure for artificial joint replacement. The inflammatory response and the production of pro‐osteoclastic factors lead to elevation of osteoclast formation and excessive activity results in extensive bone destruction around the bone‐implant interface. Here we showed that Nepetin, a natural bioactive flavonoid with proven anti‐inflammatory and anti‐proliferative properties, potently inhibited RANKL‐induced osteoclast differentiation, formation and bone resorption in vitro, and protected mice against the deleterious effects of titanium particle–induced calvarial osteolysis in vivo. Mechanistically, Nepetin attenuated RANKL‐induced activation of NF‐κB and MAPK signalling pathways and TRAF6‐dependent ubiquitination of Beclin 1 which is necessary for the induction of autophagy. In brief, our study demonstrates the potential therapeutic application of Nepetin against osteoclast‐mediated osteolytic diseases.
Bibliography:Funding information
The National Natural Science Foundation of China (80212076), Traditional Chinese Medicine of Zhejiang Province (2018ZB138) and Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (2020384729).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Binxiang Chu and Shenao Chen contributed equally to this work.
ISSN:1582-1838
1582-4934
DOI:10.1111/jcmm.16055